|
Volumn 12, Issue 8, 2001, Pages 1169-1171
|
Transformation of Hodgkin's disease to high-grade B-cell lymphoma: Remission after Rituximab monotherapy
|
Author keywords
B cell lymphoma; CD20 antigen; Hodgkin's disease; Lymphoma; Therapy; Transformation
|
Indexed keywords
BLEOMYCIN;
CD20 ANTIGEN;
CYCLOPHOSPHAMIDE;
DACARBAZINE;
DOXORUBICIN;
IBANDRONIC ACID;
PREDNISONE;
PROCARBAZINE;
RITUXIMAB;
VINBLASTINE;
VINCRISTINE;
ADULT;
ARTICLE;
B CELL LYMPHOMA;
CANCER CHEMOTHERAPY;
CANCER GRADING;
CANCER IMMUNOTHERAPY;
CANCER RECURRENCE;
CANCER REGRESSION;
CANCER STAGING;
CANCER SURGERY;
CASE REPORT;
CLINICAL PROTOCOL;
CLONE;
COMPUTER ASSISTED TOMOGRAPHY;
DRUG EFFICACY;
DRUG RESISTANCE;
FEMALE;
HODGKIN DISEASE;
HUMAN;
LUNG NODULE;
MALIGNANT TRANSFORMATION;
MEDIASTINUM;
MONOTHERAPY;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
STEM CELL TRANSPLANTATION;
SYMPTOM;
THORAX RADIOGRAPHY;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
CELL TRANSFORMATION, NEOPLASTIC;
CYCLOPHOSPHAMIDE;
DACARBAZINE;
DOXORUBICIN;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
HODGKIN DISEASE;
HUMANS;
LYMPHOMA, B-CELL;
LYMPHOMA, HIGH-GRADE;
MIDDLE AGED;
NEOPLASM STAGING;
NEOPLASMS, SECOND PRIMARY;
PREDNISONE;
PROCARBAZINE;
REMISSION INDUCTION;
VINBLASTINE;
VINCRISTINE;
|
EID: 0034828364
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1011628322057 Document Type: Article |
Times cited : (9)
|
References (15)
|